Hereditary Cancer Insight

The Privy Health Cancer Insight (CGX) identifies specific, inheritable gene mutations that may increase a person’s risk of developing cancer.

12 Different Cancer Types Analyzed

33 Genes Tested

Understand Your Risk of Hereditary Cancer

100% Confidential

Summer Sale!

Our Process

Open your CGX Insight package and register it online, filling out the registration prompts

Use 2 cheek swabs to collect your genetic sample, and return it with provided prepaid postage

Your genetic material will be submitted to and processed by a CLIA certified laboratory

In 6 to 8 weeks, you'll receive your personalized CGX insights to share with your physician


Personalized Report

Your personalized Hereditary Cancer Insight provides you with a whitepaper-backed basis analysis of all identified mutations.

This report includes facts and statistical information as it pertains to your predisposition to cancer, based on your unique genetic profile.

Benefits & Facts

  • Benefits
  • Genes
  • Cancers Tested
  • Statistics

Knowledge Is Power

Everyone is at risk of developing cancer, but what we do to lower our exposure will speak volumes when it comes to prevention and treatment. Some individuals are genetically predisposed to the development of certain types of cancers because they might run in his or her family. Genetic testing for hereditary cancer can present valuable medical information for the patient and blood relatives.

Preventative Action

Results let you work with your healthcare provider to explore lifestyle changes and medically informed decisions to reduce your cancer risk. Genetic testing increases the probability of early detection, which dramatically increases the rate of survival.

Proactive Care

If you are diagnosed with a disease, or if a family history of a disease is revealed through testing, understanding your genetics can help you make more informed treatment decisions. It can also provide insight into how particular predispositions may play a role within your family. That not only includes your children but siblings, aunts, and uncles, nieces and cousins.

Below are the genes tested within the Privy Health Cancer Genomics Insight Genetic Test. A mutation in one or more of these genes can indicate an increased risk of cancer, including breast, ovarian, colorectal, or prostate cancer.

APC

ATM

BARD1

BMPR1A

BRCA1

BRCA2

BRIP1

CDH1

CDKN2A

CHEK2

EPCAM

FH

FLCN

MLH1

MRE11A

MSH2

MSH6

MUTYH

NBN

NF1

PALB2

PMS2

PTEN

RAD50

RAD51C

RAD51D

RINT1

SDHB

SMAD4

STK11

TP53

VHL

XRCC2

Breast

Ovarian

Uterine

Endometrial

Colon

Renal

Pancreatic

Gastric

Liver

Pancreatic

Prostate

Melanoma

We test for over 12 different cancer types in our comprehensive CGX Complete Panel (see above). Results can provide a more extensive evaluation of cancer-related genes in a family.

Women's % Of Risk

In women, the presence of a BRCA1 mutation increase the chances of breast cancer up to 81% and ovarian cancer up to 54% by the age of 81.

Men's % Of Risk

In men, the presence of an APC mutation dramatically increase the probability of colorectal cancer up to 70-100% by the age of 80, if untreated.


Introduction to Cancer Genomics

Watch Video

About Privy Health

Privy Health's goal is simple: allow cutting edge, preventative medicine to be more easily accessible to patients. We partner with the brightest clinical providers and most user friendly technical solutions, while providing patient support services that you can count on.

Contact Us

GOT QUESTIONS? Reach out to us and a team member will be in contact with you to answer any questions you have.

phone: (877) 314-9884
email: info@privy.health